Therapeutic cancer vaccine

This page covers all Therapeutic cancer vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ras and CEA (carcinoembryonic antigen), Patient-specific tumor neoantigens, MAGE-1, MAGE-3 (melanoma-associated antigens).

Targets

ras and CEA (carcinoembryonic antigen) · Patient-specific tumor neoantigens · MAGE-1, MAGE-3 (melanoma-associated antigens) · WT1 (Wilms tumor antigen 1) · HER2 (human epidermal growth factor receptor 2) · Tumor-associated antigens (TAAs)

Marketed (3)

• CPA · ImmunoVaccine Technologies, Inc. (IMV Inc.) · Oncology
  CPA is a cancer immunotherapy vaccine that stimulates the immune system to recognize and attack cancer cells by presenting tumor-associated antigens.
• VEC · Centre Leon Berard · Oncology
  VEC is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.
• D-cure · KU Leuven · Oncology
  D-cure is a therapeutic vaccine designed to stimulate the immune system to recognize and eliminate cancer cells expressing specific tumor-associated antigens.

Phase 3 pipeline (13)

• PANVAC™-VF · Therion Biologics Corporation · Oncology
  PANVAC-VF is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack cancer cells expressing ras and CEA tumor-associated antigens.
• TAK-019 · Takeda · Oncology
  TAK-019 is a therapeutic vaccine designed to stimulate immune responses against cancer cells expressing specific tumor-associated antigens.
• Mevac-A vaccine · Chiang Mai University · Oncology
  Mevac-A is a therapeutic vaccine designed to stimulate immune responses against mevalonate pathway-associated antigens to treat cancer.
• CancerVax vaccine (CANVAXIN) · CancerVax Corporation · Oncology
  CANVAXIN is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.
• GSK208141 vaccine · GlaxoSmithKline · Oncology
  GSK208141 is a therapeutic vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.
• OSE2101 · GERCOR - Multidisciplinary Oncology Cooperative Group · Oncology
  OSE2101 is a therapeutic cancer vaccine that targets WT1 (Wilms tumor antigen 1) to activate the immune system against WT1-expressing tumor cells.
• MR-Vac · GlaxoSmithKline · Oncology
  MR-Vac is a therapeutic cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.
• NeuVax™ vaccine · Galena Biopharma, Inc. · Oncology
  NeuVax is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack cancer cells expressing the HER2 protein.
• Begrivac® · Chiltern Pesquisa Clinica Ltda · Oncology
  Begrivac is a therapeutic cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.
• GC3110A vaccine · Green Cross Corporation · Oncology
  GC3110A is a therapeutic cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.
• GC3110B vaccine · Green Cross Corporation · Oncology
  GC3110B is a therapeutic cancer vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.
• HAPREP® · National Cancer Center, Korea · Oncology
  HAPREP is a therapeutic cancer vaccine that primes the immune system to recognize and attack cancer cells expressing shared tumor-associated antigens.
• MSB0010718C · Istituto Oncologico Veneto IRCCS · Oncology
  MSB0010718C is a therapeutic cancer vaccine designed to activate the immune system against tumor-associated antigens.

Phase 2 pipeline (1)

• GEN-004 with Aluminum Hydroxide Adjuvant · Genocea Biosciences, Inc. · Oncology
  GEN-004 is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack tumor-associated antigens expressed on cancer cells.